Lucy Scott

669 total citations
8 papers, 355 citations indexed

About

Lucy Scott is a scholar working on Oncology, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Lucy Scott has authored 8 papers receiving a total of 355 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Lucy Scott's work include Colorectal Cancer Treatments and Studies (3 papers), CAR-T cell therapy research (2 papers) and Genetic factors in colorectal cancer (2 papers). Lucy Scott is often cited by papers focused on Colorectal Cancer Treatments and Studies (3 papers), CAR-T cell therapy research (2 papers) and Genetic factors in colorectal cancer (2 papers). Lucy Scott collaborates with scholars based in United Kingdom, Kuwait and United States. Lucy Scott's co-authors include Fahd Al‐Mulla, Graeme I. Murray, Walter Kölch, Suzanne Hagan, Shirley St. George, James J. Going, Nicky Fyfe, Milad S. Bitar, A. Behbehani and Jordi Curto and has published in prestigious journals such as Journal of Clinical Oncology, eLife and Histopathology.

In The Last Decade

Lucy Scott

7 papers receiving 350 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lucy Scott United Kingdom 5 253 165 111 27 27 8 355
Jan Bražina Czechia 9 306 1.2× 210 1.3× 37 0.3× 37 1.4× 28 1.0× 14 393
Pyoung Hwa Park United States 7 438 1.7× 165 1.0× 149 1.3× 20 0.7× 11 0.4× 8 498
Seamus P. Ragan United States 8 183 0.7× 174 1.1× 45 0.4× 38 1.4× 7 0.3× 11 350
Hyung-Seok Hur South Korea 5 204 0.8× 203 1.2× 44 0.4× 19 0.7× 5 0.2× 6 315
Chinnadurai Mani United States 14 363 1.4× 225 1.4× 29 0.3× 31 1.1× 6 0.2× 31 474
David Remillard United States 10 725 2.9× 184 1.1× 153 1.4× 56 2.1× 4 0.1× 11 797
Janine M. Buonato United States 8 203 0.8× 141 0.9× 31 0.3× 36 1.3× 5 0.2× 10 322
Jennifer Kimberly Lue United States 11 244 1.0× 146 0.9× 170 1.5× 94 3.5× 3 0.1× 40 435
Amanda Balboni Iniguez United States 7 470 1.9× 207 1.3× 45 0.4× 33 1.2× 9 0.3× 7 604
Lisa Kashima Japan 8 270 1.1× 144 0.9× 29 0.3× 34 1.3× 13 0.5× 9 367

Countries citing papers authored by Lucy Scott

Since Specialization
Citations

This map shows the geographic impact of Lucy Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lucy Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lucy Scott more than expected).

Fields of papers citing papers by Lucy Scott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lucy Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lucy Scott. The network helps show where Lucy Scott may publish in the future.

Co-authorship network of co-authors of Lucy Scott

This figure shows the co-authorship network connecting the top 25 collaborators of Lucy Scott. A scholar is included among the top collaborators of Lucy Scott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lucy Scott. Lucy Scott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Taylor, Gillian C.A., Lucy Scott, Alex von Kriegsheim, et al.. (2022). Rapid and specific degradation of endogenous proteins in mouse models using auxin-inducible degrons. eLife. 11. 26 indexed citations
2.
Hartmann, Daniel, Guido von Figura, Zhangfa Song, et al.. (2014). Plasma N -acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome. Future Oncology. 11(2). 193–203. 4 indexed citations
3.
Plummer, Ruth, Paul Lorigan, Neil Steven, et al.. (2013). A phase II study of the potent PARP inhibitor, Rucaparib (PF-01367338, AG014699), with temozolomide in patients with metastatic melanoma demonstrating evidence of chemopotentiation. Cancer Chemotherapy and Pharmacology. 71(5). 1191–1199. 143 indexed citations
4.
Doyle, Brendan, Suzanne Hagan, Fahd Al‐Mulla, et al.. (2012). Raf kinase inhibitor protein expression combined with peritoneal involvement and lymphovascular invasion predicts prognosis in Dukes' B colorectal cancer patients. Histopathology. 62(3). 505–510. 13 indexed citations
5.
Al‐Mulla, Fahd, Suzanne Hagan, A. Behbehani, et al.. (2006). Raf Kinase Inhibitor Protein Expression in a Survival Analysis of Colorectal Cancer Patients. Journal of Clinical Oncology. 24(36). 5672–5679. 148 indexed citations
6.
Scott, Lucy, Jeff White, Robin Reid, & Fiona Cowie. (2005). Management of Skin Toxicity Related to the Use of ImatinibMesylate (STI571, Glivec™) for Advanced Stage GastrointestinalStromal Tumours. Sarcoma. 9(3-4). 157–160. 17 indexed citations
7.
Scott, Lucy, Judith Fraser, & Jim Cassidy. (2003). Emerging drugs in colorectal cancer. Expert Opinion on Emerging Drugs. 8(1). 193–202. 3 indexed citations
8.
Scott, Lucy & Chris Twelves. (2003). Cost-Effective Strategies in the Management of Advanced Colorectal Cancer. 2(2). 111–124. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026